FIELD: biotechnology.
SUBSTANCE: invention relates to investigation of biomaterials and tissue engineering, namely, to a method of producing modified alginate microspheres, involving liver decellularization, its mechanical slicing and further mechanical milling to produce microparticles of decellularized liver, that is fixed by covalent binding on preliminary prepared alginate microspheres, modified using modifying agents, such as hydroxysuccinimide (NHS) and hydrochloride N-(3-dimethylaminopropyl)-N-ethylcarbodiimide (EDC). Invention provides high density of microparticles of decellularized hepatic tissue on the surface of modified alginate microcarriers and a strong covalent bond between them.
EFFECT: proposed modified alginate microspheres can act as biodegradable container for biologically active substances and/or cells, as well as to protect the cells, encapsulated inside alginate microcarriers from act of recipient's immune system when implanted.
7 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING BIODEGRADABLE SKAFFOLDS FROM SILK FIBROIN WITH IMPROVED BIOLOGICAL PROPERTIES | 2017 |
|
RU2683557C1 |
COMPOSITION FOR THE MANUFACTURE OF BIODEGRADABLE SCAFFOLDS AND THE METHOD OF ITS PREPARATION | 2017 |
|
RU2684769C1 |
BIORESORBABLE MICRO-CARRIER FOR CELL DELIVERY TO REGION OF WOUND HEALING AND REGENERATION | 2015 |
|
RU2616866C1 |
METHOD FOR PREPARING TISSUE-SPECIFIC MATRIX FOR TISSUE ENGINEERING OF PARENCHYMAL ORGAN | 2013 |
|
RU2539918C1 |
METHOD OF PRODUCING TISSUE-SPECIFIC MATRIX FOR TISSUE ENGINEERING OF CARTILAGE | 2019 |
|
RU2716577C1 |
TISSUE-SPECIFIC MATRIX FOR TISSUE ENGINEERING OF THE PARENCHYMAL ORGAN AND A METHOD FOR PREPARING IT | 2016 |
|
RU2693432C2 |
INCAPSULATION SYSTEM | 2006 |
|
RU2429864C2 |
COMPOSITION OF ENCAPSULATED LIVER CELLS | 2010 |
|
RU2564924C2 |
INCAPSULATED HEPATOCYTE COMPOSITION | 2010 |
|
RU2500390C2 |
TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
Authors
Dates
2017-01-10—Published
2015-10-22—Filed